Women who use the popular Ortho Evra patch for birth-control are exposed to as much as 60 percent more estrogen than women who use typical birth-control pills, according to a new warning issued by the drug’s manufacturer. High estrogen levels are associated with an increased risk of developing potentially fatal blood clots (strokes).
In a news release accompanying the November 10, 2005, announcement of the warning, the Food and Drug Administration stated that Ortho McNeil, the manufacturer of the Ortho Evra patch, currently is conducting studies to compare the risks of developing serious blood clots, in women using the Ortho Evra patch with the risks caused by typical birth control pills.[1]
An Associated Press investigation published in July 2005 reported that women on the Ortho Evra patch were three times more likely to die or be injured by a blood clot than women on the pill.[2] The AP report indicated that potential Ortho Evra patch deaths have been reported in about a dozen young women in 2004. [3] The report was based on an analysis of federal drug-safety reports from 2004. During that year, according to the Associated Press, annual American sales of the Ortho Evra patch reached an estimated $400 million. [4]
If you or someone you know has been injured or killed by a blood clot while using Ortho Evra patch and you wish to consult with us, please call our lawyers by sending an e-mail here: contact us.
[1] “FDA Updates Labeling for Ortho Evra Contraceptive Patch,” FDA News, http://www.fda.gov/bbs/topics/news/2005/NEW01262.html[2] Martha Mendoza, “Birth Control Patch May Have Higher Risk,” The Associated Press, July 16, 2005.
[3] Martha Mendoza, “Millions Spent on Birth-Control Patch Ads,” The Associated Press, July 16, 2005.
[4] Martha Mendoza, “Millions Spent on Birth-Control Patch Ads,” The Associated Press, July 16, 2005.
Related Attorneys
Partner
